Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 27th:
ArcBest Corporation (ARCB - Free Report) : This freight transportation services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.9% over the last 60 days.
ArcBest Corporation Price and Consensus
ArcBest has a PEG ratio of 0.43, compared with 0.95 for the industry. The company possesses a Growth Score of A.
ArcBest Corporation PEG Ratio (TTM)
Conn's, Inc. (CONN - Free Report) : This specialty retailer of durable consumer goods, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.7% over the last 60 days.
Conn's, Inc. Price and Consensus
Conn's has a PEG ratio of 0.68, compared with 0.78 for the industry. The company possesses a Growth Score of A.
Conn's, Inc. PEG Ratio (TTM)
Xcerra Corporation : This test and handling capital equipment provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 1% over the last 60 days.
Xcerra Corporation Price and Consensus
Xcerra has a PEG ratio of 1.13, compared with 1.97 for the industry. The company possesses a Growth Score of A.
Xcerra Corporation PEG Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, July 27th:
ArcBest Corporation (ARCB - Free Report) : This freight transportation services provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.9% over the last 60 days.
ArcBest Corporation Price and Consensus
ArcBest has a PEG ratio of 0.43, compared with 0.95 for the industry. The company possesses a Growth Score of A.
ArcBest Corporation PEG Ratio (TTM)
Conn's, Inc. (CONN - Free Report) : This specialty retailer of durable consumer goods, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.7% over the last 60 days.
Conn's, Inc. Price and Consensus
Conn's has a PEG ratio of 0.68, compared with 0.78 for the industry. The company possesses a Growth Score of A.
Conn's, Inc. PEG Ratio (TTM)
Xcerra Corporation : This test and handling capital equipment provider, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 1% over the last 60 days.
Xcerra Corporation Price and Consensus
Xcerra has a PEG ratio of 1.13, compared with 1.97 for the industry. The company possesses a Growth Score of A.
Xcerra Corporation PEG Ratio (TTM)
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CONN - FREE
Get the latest research report on ARCB - FREE